Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8 Multiple Myeloma 6 Neoplasms, Plasma Cell 4 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Prostatic Neoplasms 3 Leukemia, Myelomonocytic, Chronic 3 Sarcoma 2 Myeloproliferative Disorders 2 Lymphoma 2 Lung Neoplasms 2 Inflammation 2 Frailty 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Ventilator-Induced Lung Injury 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Postoperative Complications 1 Pancreatic Diseases 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Mucositis 1

Interventions

Oxaliplatin 146 Fluorouracil 137 Capecitabine 121 Leucovorin 106 Irinotecan 85 Radiotherapy 66 Bevacizumab 64 Cetuximab 46 Folfox protocol 27 Surgical Procedures, Operative 23 Radiation 23 Drug Therapy 22 Panitumumab 19 XELOX 18 Chemotherapy, Adjuvant 15 Neoadjuvant Therapy 14 Radiotherapy, Intensity-Modulated 13 Chemoradiotherapy 13 Magnetic Resonance Spectroscopy 11 regorafenib 10 Nivolumab 10 Floxuridine 10 sintilimab 8 raltitrexed 8 Specimen Handling 8 IFL protocol 8 Celecoxib 8 Biopsy 8 trifluridine tipiracil drug combination 7 tislelizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rectal Neoplasms × Ascorbic Acid × Clear all

NCT04801511 2021-03-17

CORT

Zhongnan Hospital

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡